Natural moisturizing factor as a biomarker for filaggrin mutation status in a multi-ethnic paediatric atopic dermatitis cohort

Minke M. F. van Mierlo; Peter J. Caspers; Marieke S. Jansen; Gerwin J. Puppels; Anouk E. M. Nouwen; Madelon B. Bronner; Luba M. Pardo; Michel van Geel; Suzanne G. M. A. Pasmans

doi:10.1111/cea.14001

Natural moisturizing factor as a biomarker for filaggrin mutation status in a multi-ethnic paediatric atopic dermatitis cohort

Minke M. F. van Mierlo, Peter J. Caspers, Marieke S. Jansen, Gerwin J. Puppels, Anouk E. M. Nouwen, Madelon B. Bronner, Luba M. Pardo, Michel van Geel, Suzanne G. M. A. Pasmans

Dermatology

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

10 Citations (Scopus)

43 Downloads (Pure)

Original language	English
Pages (from-to)	1510-1513
Number of pages	4
Journal	Clinical & Experimental Allergy
Volume	51
Issue number	11
Early online date	19 Aug 2021
DOIs	https://doi.org/10.1111/cea.14001
Publication status	Published - Nov 2021

Bibliographical note

Funding information:
The gen2-SCA Skin Composition Analyzer used was funded by a grant from the Stichting Jacoba. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The Department of Dermatology of the Erasmus MC University Medical Center Rotterdam received an unrestricted grant from Micreos Human Health, the Netherlands.

Access to Document

10.1111/cea.14001

cea.14001

Cite this

van Mierlo, M. M. F., Caspers, P. J., Jansen, M. S., Puppels, G. J., Nouwen, A. E. M., Bronner, M. B., Pardo, L. M., van Geel, M., & Pasmans, S. G. M. A. (2021). Natural moisturizing factor as a biomarker for filaggrin mutation status in a multi-ethnic paediatric atopic dermatitis cohort. Clinical & Experimental Allergy, 51(11), 1510-1513. https://doi.org/10.1111/cea.14001

@article{0ff800aa4be94ed386d2b04f7b17c941,

title = "Natural moisturizing factor as a biomarker for filaggrin mutation status in a multi-ethnic paediatric atopic dermatitis cohort",

author = "\{van Mierlo\}, \{Minke M. F.\} and Caspers, \{Peter J.\} and Jansen, \{Marieke S.\} and Puppels, \{Gerwin J.\} and Nouwen, \{Anouk E. M.\} and Bronner, \{Madelon B.\} and Pardo, \{Luba M.\} and \{van Geel\}, Michel and Pasmans, \{Suzanne G. M. A.\}",

note = "Funding information: The gen2-SCA Skin Composition Analyzer used was funded by a grant from the Stichting Jacoba. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The Department of Dermatology of the Erasmus MC University Medical Center Rotterdam received an unrestricted grant from Micreos Human Health, the Netherlands.",

year = "2021",

month = nov,

doi = "10.1111/cea.14001",

language = "English",

volume = "51",

pages = "1510--1513",

journal = "Clinical \& Experimental Allergy",

issn = "0954-7894",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "11",

}

Natural moisturizing factor as a biomarker for filaggrin mutation status in a multi-ethnic paediatric atopic dermatitis cohort. / van Mierlo, Minke M. F.; Caspers, Peter J.; Jansen, Marieke S. et al.
In: Clinical & Experimental Allergy, Vol. 51, No. 11, 11.2021, p. 1510-1513.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Natural moisturizing factor as a biomarker for filaggrin mutation status in a multi-ethnic paediatric atopic dermatitis cohort

AU - van Mierlo, Minke M. F.

AU - Caspers, Peter J.

AU - Jansen, Marieke S.

AU - Puppels, Gerwin J.

AU - Nouwen, Anouk E. M.

AU - Bronner, Madelon B.

AU - Pardo, Luba M.

AU - van Geel, Michel

AU - Pasmans, Suzanne G. M. A.

N1 - Funding information: The gen2-SCA Skin Composition Analyzer used was funded by a grant from the Stichting Jacoba. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The Department of Dermatology of the Erasmus MC University Medical Center Rotterdam received an unrestricted grant from Micreos Human Health, the Netherlands.

PY - 2021/11

Y1 - 2021/11

U2 - 10.1111/cea.14001

DO - 10.1111/cea.14001

M3 - Comment/Letter to the editor

C2 - 34411363

SN - 0954-7894

VL - 51

SP - 1510

EP - 1513

JO - Clinical & Experimental Allergy

JF - Clinical & Experimental Allergy

IS - 11

ER -